当前位置: 首页 > 详情页

MAPT IVS1+124 C > G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals

| 导出 | |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China [b]Department of Neurology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China [c]Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing, China [d]Key Laboratory on Parkinson’s Disease of Beijing, Beijing, China [e]Department of Neurology, The Affiliated Sanming First Hospital of Fujian Medical University, Sanming, Fujian, China [f]Chinese National Human Genome Center, Beijing, China [g]Parkinson’s Disease Center of Beijing Institute of Brain Disorders, Beijing, China
出处:
ISSN:

关键词: Parkinson's disease Genetic association MAPT LRRK2 Interaction

摘要:
Variants of the MAPT gene have been suggested to be associated with Parkinson's disease (PD) and to modify the risk for leucine-rich repeat kinase 2 (LRRK2) Parkinsonism. However, this has not been confirmed in Asians with ethnicity-specific variants of MAPT and LRRK2. In this study, Asian-specific LRRK2 p. G2385R variant and IVS1 broken vertical bar 124 C>G, a functional single-nucleotide polymorphism located in the MAPT promoter region, were genotyped in 561 Chinese PD patients and 556 control subjects. Allelic and genotypic frequencies of the 2 variants were compared between cases and control subjects independently and in combination. As a result, the LRRK2 p. G2385R variant alone was associated with an increased risk for PD (Odds ratio, 1.86; 95% confidence intervals, 1.08-3.19; p = 0.014), whereas MAPT IVS1+124 C>G was not (p = 0.34). However, the coexistence of MAPT IVS1+124C>G significantly enhanced the LRRK2 G2385R-conferred risk for PD (Odds ratio, 2.30; 95% confidence intervals, 1.14-4.54; p = 0.012). These results provide further evidence supporting the interaction between MAPT and LRRK2 genes, which increases the susceptibility to PD in Chinese individuals. (C) 2014 Elsevier Inc. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 2 区 医学
小类 | 2 区 老年医学 2 区 神经科学
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 老年医学 3 区 神经科学
JCR分区:
出版当年[2012]版:
Q1 NEUROSCIENCES Q1 GERIATRICS & GERONTOLOGY
最新[2023]版:
Q2 GERIATRICS & GERONTOLOGY Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2012版] 出版当年五年平均 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者机构: [a]Department of Neurobiology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China [b]Department of Neurology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China [c]Key Laboratory on Neurodegenerative Disorders of Ministry of Education, Beijing, China [d]Key Laboratory on Parkinson’s Disease of Beijing, Beijing, China
通讯作者:
通讯机构: [*1]Department of Neurobiology & Neurology, Xuanwu Hospital of Capital Medical University, #45 Changchun Street, 100053 Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:17069 今日访问量:0 总访问量:918 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院